Clemson University
Magnetic Resonance Imaging Trackable Pathology-Triggered Polymersomes Toward Enzyme Replacement Theranostics for GM1 Gangliosidosis
Abstract
dc:description.abstractThis dissertation investigates the development and optimization of pathology-responsive polymersomes for simultaneous enhanced magnetic resonance imaging (MRI) and enzyme replacement therapy (ERT) in the treatment of GM1 gangliosidosis (GM1). While therapeutic strategies exist for similar, non-neuropathic lysosomal storage disorders, implementation towards GM1 faces significant challenges due to the blood-brain barrier. Herein, we developed and characterized a range of low molecular weight hyaluronic acid-b-polylactic acid (HA-PLA) polymersomes (PSs) capable of encapsulating therapeutic enzymes in their hydrophilic core. These polymersomes exhibit pathophysiology-triggered responsiveness, degrading in the presence of acidic conditions, which is characteristic of lysosomes, and enzymes such as hexosaminidase A, which is elevated as a compensatory result of GM1. The work presented in this dissertation contributes to the advancement of nanotechnology-based theranostics, emphasizing the integration of diagnostic and therapeutic functions in a single, responsive system. Our findings open new avenues for the treatment of lysosomal storage disorders and other conditions requiring targeted delivery across the blood-brain barrier.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy (PhD)
- Level thesis:degree_level
- Dissertation
- Discipline thesis:degree_discipline
- Chemical and Biomolecular Engineering
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Foster, Dorian
- Contributors dc:contributor
-
- Jessica Larsen
- Marc Birtwistle
- Scott Husson
- Angela Alexander Bryant
Subjects
dc:subject × 10Identifiers
dc:identifier.*- Repository record dc:identifier
- https://open.clemson.edu/all_dissertations/3839